Georgy Berezhnoy

Mr. Georgy Berezhnoy

University Hospital Tuebingen, Tübingen, Baden-Württemberg, Germany
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Heliyon
Verified
Journal Article
Open access
YSYogesh Singh
Yogesh Singh
CTChristoph Trautwein
Christoph Trautwein
RFRolf Fendel
Rolf Fendel
NKNaomi Krickeberg
Naomi Krickeberg
Georgy BerezhnoyGeorgy Berezhnoy
Georgy Berezhnoy
OROlaf Riess
Olaf Riess
The SARS-CoV-2 virus is the causative agent of the global COVID-19 infectious disease outbreak, which can lead to acute respiratory distress syndrome (ARDS). However, it is still unclear how the virus interferes with immune cell and metabolic functions in the human body. In this study, we investigated the immune response in acute or convalescent COVID19 patients. We characterized the peripheral blood mononuclear cells (PBMCs) using flow cytometry and found that CD8+ T cells were significantly subsided in moderate COVID-19 and convalescent patients. Furthermore, characterization of CD8+ T cells suggested that patients with a mild and moderate course of the COVID-19 disease and convalescent patients have significantly diminished expression of both perforin and granzyme A in CD8+ T cells. Using 1H-NMR spectroscopy, we characterized the metabolic status of their autologous PBMCs. We found that fructose, lactate and taurine levels were elevated in infected (mild and moderate) patients compared with control and convalescent patients. Glucose, glutamate, formate and acetate levels were attenuated in COVID-19 (mild and moderate) patients. In summary, our report suggests that SARS-CoV-2 infection leads to disrupted CD8+ T cytotoxic functions and changes the overall metabolic functions of immune cells.

Verified
Journal Article
Open access
PDF file
Georgy BerezhnoyGeorgy Berezhnoy
Georgy Berezhnoy
CLChristoph Laske
Christoph Laske
CTChristoph Trautwein
Christoph Trautwein
Alzheimer’s disease (AD) is the most common form of dementia in the elderly and has been associated with changes in lipoprotein metabolism. We performed quantitative lipoprotein analysis in a local cohort of cognitively impaired elderly and control subjects using standardized nuclear magnetic resonance (NMR) spectroscopy. A commercially available quantitative NMR-based assay covering 112 lipoprotein main and subtype variables was used to investigate blood serum samples from a moderate cohort size of 161 persons (71 female, 90 male), including measures of quality control. Additionally, clinical metadata and cerebrospinal fluid AD biomarkers were collected and used for analysis. High-density lipoprotein (HDL) HDL-4 subfraction levels were mostly high in female individuals with mild cognitive impairment (MCI), followed by AD. Low-density lipoprotein (LDL) LDL-2 cholesterol was slightly elevated in male AD patients. HDL-2 apolipoprotein Apo-A1, HDL-2 phospholipids, and HDL-3 triglycerides were highly abundant in AD and MCI women compared to men. When considering clinical biomarkers (Aβ, tau), very low-density lipoprotein (VLDL) VLDL-1 and intermediate-density lipoprotein (IDL) triglycerides were substantially higher in AD compared to MCI. In addition, triglyceride levels correlated positively with dementia. Different lipoprotein serum patterns were identified for AD, MCI, and control subjects. Interestingly, HDL-4 and LDL-2 cholesterol parameters revealed strong gender-specific changes in the context of AD-driven dementia. As gender-based comparisons were based on smaller sub-groups with a low n-number, several statistical findings did not meet the significance threshold for multiple comparisons testing. Still, our finding suggests that serum HDL-4 parameters and various triglycerides correlate positively with AD pathology which could be a read-out of extended lipids traveling through the blood-brain barrier, supporting amyloid plaque formation processes. Thereof, we see herein a proof of concept that this quantitative NMR-based lipoprotein assay can generate important and highly interesting data for refined AD diagnosis and patient stratification, especially when larger cohorts are available.

19 June 2020 in Inorganic Chemistry
Verified
Journal Article
Closed access
AMAlexander Martynov
Alexander Martynov
MPMarina A. Polovkova
Marina A. Polovkova
Georgy BerezhnoyGeorgy Berezhnoy
Georgy Berezhnoy
ASAnna A. Sinelshchikova
Anna A. Sinelshchikova
FDFedor M. Dolgushin
Fedor M. Dolgushin
ATAslan Yu. Tsivadze
Aslan Yu. Tsivadze

16 December 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
TRTitus Rössler
Titus Rössler
Georgy BerezhnoyGeorgy Berezhnoy
Georgy Berezhnoy
YSYogesh Singh
Yogesh Singh
CCClaire Cannet
Claire Cannet
TRTony Reinsperger
Tony Reinsperger
CTChristoph Trautwein
Christoph Trautwein
The complex manifestations of COVID-19 are still not fully decoded on the molecular level. We combined quantitative the nuclear magnetic resonance (NMR) spectroscopy serum analysis of metabolites, lipoproteins and inflammation markers with clinical parameters and a targeted cytokine panel to characterize COVID-19 in a large (534 patient samples, 305 controls) outpatient cohort of recently tested PCR-positive patients. The COVID-19 cohort consisted of patients who were predominantly in the initial phase of the disease and mostly exhibited a milder disease course. Concerning the metabolic profiles of SARS-CoV-2-infected patients, we identified markers of oxidative stress and a severe dysregulation of energy metabolism. NMR markers, such as phenylalanine, inflammatory glycoproteins (Glyc) and their ratio with the previously reported supramolecular phospholipid composite (Glyc/SPC), showed a predictive power comparable to laboratory parameters such as C-reactive protein (CRP) or ferritin. We demonstrated interfaces between the metabolism and the immune system, e.g., we could trace an interleukin (IL-6)-induced transformation of a high-density lipoprotein (HDL) to a pro-inflammatory actor. Finally, we showed that metadata such as age, sex and constitution (e.g., body mass index, BMI) need to be considered when exploring new biomarkers and that adding NMR parameters to existing diagnoses expands the diagnostic toolbox for patient stratification and personalized medicine.

1 January 2019 in Macroheterocycles
Verified
Journal Article
Closed access
AMAlexander Martynov
Alexander Martynov
Georgy BerezhnoyGeorgy Berezhnoy
Georgy Berezhnoy
ESEvgeniya A. Safonova
Evgeniya A. Safonova
MPMarina A. Polovkova
Marina A. Polovkova
YGYulia G. Gorbunova
Yulia G. Gorbunova
ATAslan Yu. Tsivadze
Aslan Yu. Tsivadze

2 June 2021 in Inorganic Chemistry
Verified
Journal Article
Closed access
AMAlexander Martynov
Alexander Martynov
MPMarina A. Polovkova
Marina A. Polovkova
Georgy BerezhnoyGeorgy Berezhnoy
Georgy Berezhnoy
ASAnna A. Sinelshchikova
Anna A. Sinelshchikova
VKVictor N. Khrustalev
Victor N. Khrustalev
ATAslan Yu. Tsivadze
Aslan Yu. Tsivadze